1. VarioSys
  2. Information
  3. Innovation Award

Interphex Award 2016 Biotech Innovation

INTERPHEX, Pharmaceutical Processing, and a team of industry experts select six winners for this year's exhibitor awards.
NEW YORK, NY, April 26, 2016 - International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral Drug Association (PDA), today announced the winners for the INTERPHEX Exhibitor Awards for 2016. The awards—sponsored by Pharmaceutical Processing, the leading source of pharmaceutical and biopharmaceutical manufacturing news—were broken into six categories: best in show, best new product/service, editor’s choice, best technological innovation, efficiency champion, and biotech innovation award. The Exhibitor Awards program was launched in November of 2014, and the latter two awards, efficiency champion and biotech innovation award, were added this year.

The judges on this year’s Exhibitor Awards panel were Meg LaTorre-Snyder, Editor of Pharmaceutical Processing, David Hall, Vice President of Sales for Parenteral Drug Association (PDA), Christa Myers, Process Chemical Engineer for CRB, Patrick Poisson, SVP Manufacturing and Chief Manufacturing Officer for the United Therapeutics Corp., and Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association (PBOA).

On behalf of INTERPHEX, the judges are pleased to present this year’s winners.

Biotech Innovation Award
Biotech Innovation Award
Bausch+Stroebel was recognized for VarioSys®, a flexible processing line based on the lock-and-key principle. This pharmaceutical production system features a flexible pharmaceutical/biotechnological processing line, modular design, and standardization of subassemblies. In a special isolator enabling production in clean room class A conditions, individual production modules can be installed that fit on the lock-and-key principle—for instance, a machine for processing syringes in nests or a filling and closing machine for vials.

Link to the interview...
GE Healthcare Life Sciences was recognized for KUBio™, a prefabricated cGMP-compliant facility and process solution designed for the scalable and cost-efficient production of modular autonomous biosamplers (mAbs). Prevalidated modular units and processing equipment are transported to a specified site. They are assembled on site, and the resulting facility is qualified and ready-to-run within 14 to 18 months.
Nemera was recognized for Novelia® BFS, a preservative-free multi-dose eyedropper combined with bottlepack® technology. Novelia® works with high viscosity suspensions and solutions of up to 1500 cps and limits the distribution of liquids to one drop at a time. The doses of the drops are precise, which intended to assist medication adherence.
Catalent Pharma Solutions was recognized for OptiForm® Solution Suite, a detailed molecule assessment with high throughput screening and parallel assessment of formulation technologies. It is designed to help solve complex bioavailability challenges for early stage molecules using a unique toolkit of bioavailability enhancing technologies. OptiForm® Solution Suite matches the best formulation technologies to a molecule and utilizes an accelerated parallel screening and development approach.
Videojet Technologies was recognized for Videojet® 7510 50-Watt Fiber Laser Marker, a laser marking system with high contrast marking on robust plastic packaging, metal containers, as well as other industrial products. Operating on speeds on to 440m/min., this technology delivers better mark quality and has a smaller marking unit, compared to traditional solid state laser systems.
Millipore Sigma was recognized for Mobius® 1000 L Single-Use Bioreactor, a stirred tank bioreactor that configures software, hardware, and single-use assemblies for use in suspension and adherent cell culture applications. It functions as a standalone system or integrated as part of a facility’s automation platform.